재처리 의료기기 시장 : 규모, 점유율 및 동향 분석 보고서 - 제품별, 유형별, 최종 용도별, 지역별 부문 예측(2025-2030년)

Reprocessed Medical Devices Market Size, Share & Trends Analysis Report By Product (Cardiovascular, Laparoscopic), By Type (Third-party, In-house), By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,242,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,398,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

재처리 의료기기 시장 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 재처리 의료기기 시장 규모는 2030년까지 50억 8,000만 달러에 달할 것으로 추정되며, 2025년부터 2030년에 걸쳐 16.95%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예측되고 있습니다.

합리적인 가격으로 효과적인 의료기기에 대한 요구가 높아지고 의료 시설에서 발생하는 의료 폐기물 증가에 대한 우려 증가가 시장을 견인한다고 보여지고 있습니다. 의료 기기 재처리 업체 협회(AMDR)에 따르면 이러한 재처리된 기기는 일반적으로 새 제품보다 30-50% 저렴합니다.

또한 의료 품질을 보장하면서 인원의 증원 및 장비 업데이트와 같은 중요한 분야에 자금을 돌릴 수 있습니다. 또한 AMDR에서 발표한 데이터에 따르면 병원은 미국 온실가스 배출량의 8.5%, 전 세계의 온실가스 배출량의 5%를 책임지고 있는 것으로 나타났습니다. 연구에 따르면, 이러한 배출은 미국의 평균 수명을 388,000년 축소하고 있습니다. 탄소 배출량의 80% 이상이 의료 공급망에서 발생합니다. 프라운호퍼 환경, 안전 및 에너지 기술 연구소에서 실시한 2021년 연구에 따르면 재처리된 의료 기기를 사용하면 이러한 기기가 지구 온난화에 미치는 영향을 40%, 오존층 파괴를 90%, 유한한 비생물 자원의 활용을 29%까지 크게 줄일 수 있다고 결론지었습니다.

재처리는 폐기물을 줄이고 제품의 수명을 연장함으로써 이 과제를 해결하는 데 도움이 됩니다. 이러한 모든 요인은 예측 기간 동안 업계 성장을 가속할 것으로 예측됩니다. 예를 들어, 2023년 1월, Vanguard AG는 영국 최대의 가장 유명한 의료기관 중 하나인 리즈 티칭 호스피탈스 NHS 트러스트와의 전략적 제휴를 발표하였습니다.

재처리 의료기기 시장 : 분석 개요

• 2024년 시장은 심장혈관분야가 56.62%의 수익 점유율로 최대를 차지했으며, 예측기간 중 17.20%로의 가장 빠른 CAGR을 나타낼 것으로 예측됩니다.
• 2024년 시장은 재처리업체 분야가 66.47%의 최대 수익 점유율로 지배적이었습니다.
• 2024년 시장 점유율은 병원 부문이 42.57%로 최대였습니다.
• 북미의 재처리 의료기기 산업은 2024년에 46.11%의 최대 수익 점유율로 세계의 시장을 독점했습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 재처리 의료기기 시장 : 변동 요인, 경향 및 범위

• 시장 연관 전망
  • 상위 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 재처리 의료기기 시장 부문 분석 : 제품별(2018-2030년)

• 재처리 의료기기 시장 : 변동 분석과 시장 점유율, 제품별
• 재처리 의료기기 시장 : 부문 대시보드
• 심혈관 기기
  • 심혈관 기기 시장(2018-2030년)
  • 혈압 커프
  • 포지셔닝 기기
• 포지셔닝 기기 시장(2018-2030년)
  • 심장 안정화 기기
  • 진단 전기 생리학 카테터
  • 심부정맥 혈전증 압축 슬리브
  • 전기 생리학 케이블
• 복강경 기기
  • 복강경 기기 시장(2018-2030년)
  • 고조파 메스
  • 내시경 투관침
• 소화기 기기
  • 소화기 기기 시장(2018-2030년)
  • 생검 포셉
  • 기타
• 일반 수술 기기
  • 일반 수술 기기 시장(2018-2030년)
  • 압력 가방
  • 풍선 팽창 기기
• 정형외과 기기
  • 정형외과 기기 시장(2018-2030년)

제5장 재처리 의료기기 시장 부문 분석 : 유형별(2018-2030년)

• 재처리 의료기기 시장 : 변동 분석과 시장 점유율, 유형별
• 재처리 의료기기 시장 : 유형별 대시보드
• 제3자 재처리
  • 제3자 재처리 시장(2018-2030년)
• 사내 재처리
  • 사내 재처리 시장(2018-2030년)

제6장 재처리 의료기기 시장 부문 분석 : 최종 용도별(2018-2030년)

• 재처리 의료기기 시장 : 변동 분석과 시장 점유율, 최종 용도별
• 재처리 의료기기 시장 : 최종 용도별 대시보드
• 병원
  • 병원 시장(2018-2030년)
• 재택치료
  • 재택치료 시장(2018-2030년)
• 기타
  • 기타 시장(2018-2030년)

제7장 재처리 의료기기 시장 부문 분석 : 지역별·제품별·용도별(2018년-2030년)

• 시장 대시보드 : 지역별
• 지역별 시장 : 주요 포인트
• 북미
  • 북미의 재처리 의료기기 시장(2018-2030년)
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 재처리 의료기기 시장(2018-2030년)
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업 분류
• 기업 프로파일
  • Stryker
  • Innovative Health
  • NEScientific, Inc.
  • Medline Industries, LP.
  • Arjo
  • Cardinal Health
  • SureTek Medical
  • Soma Tech Intl
  • Johnson &Johnson MedTech
  • GE Healthcare

KTH

영문 목차

영문목차

Reprocessed Medical Devices Market Growth & Trends:

The global reprocessed medical devices market size is estimated to reach USD 5.08 billion by 2030, registering to grow at a CAGR of 16.95% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing need for affordable & effective medical devices and growing concern regarding the rising amounts of medical waste generated by healthcare facilities are expected to drive the market. In addition, the long-term cost-efficiency associated with these devices as compared to that of the original device is expected to further drive the market growth. Medical device reprocessing has become an increasingly popular way of saving costs among healthcare organizations. According to the Association of Medical Device Reprocessors (AMDR), these reprocessed devices are typically 30-50% cheaper than new ones. Hospitals and other healthcare facilities take advantage of this cost-effective resource to enhance services and advance their technology.

It also allows them to allocate funds to important areas like hiring additional personnel or updating equipment, while still ensuring quality of care. Moreover, data published by the AMDR reveals that hospitals are responsible for 8.5% of the Greenhouse Gas (GHG) emissions in the U.S. and 5% of global outputs. Studies suggest these emissions reduce life expectancy in the U.S. by 388,000 disability-adjusted years. Over 80% of emissions come from the healthcare supply chain. A 2021 study conducted by the Fraunhofer Institute for Environmental, Safety, and Energy Technology concluded that using reprocessed medical equipment could drastically reduce the global warming impact of such devices by 40%, reduce ozone depletion by 90%, and diminish the utilization of the finite abiotic resources by 29%. The COVID-19 pandemic had a significant impact on the market. However, an increasing amount of medical waste around the world has become a major concern.

Reprocessing can help address this challenge by reducing waste and prolonging the life of products. Medical device reprocessors have begun introducing sustainable solutions to improve waste management and prevent health risks to the public, patients, healthcare staff, and waste workers. All such factors are expected to drive the industry growth during the forecast period. Several medical device companies, including subsidiaries of prominent organizations, such as Arjo, Cardinal, Medline, and Stryker, engage in remanufacturing Single-Use Devices (SUDs) as part of their sustainability initiatives. For instance, in January 2023, Vanguard AG announced its strategic partnership with Leeds Teaching Hospitals NHS Trust, one of the UK's largest and most prominent healthcare providers. This collaboration aims to promote the use of remanufactured medical devices to reduce costs and foster a more sustainable healthcare environment.

Reprocessed Medical Devices Market Report Highlights:

• The cardiovascular segment dominated the market in 2024 with the largest revenue share of 56.62% and is also anticipated to register the fastest CAGR of 17.20% over the forecast period.
• The third-party reprocessing segment dominated the market in 2024 with the largest revenue share of 66.47%.
• The hospitals segment dominated the market in 2024 with the largest revenue share of 42.57%.
• The North America reprocessed medical devices industry dominated globally in 2024 with the largest revenue share of 46.11%.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Reprocessed Medical Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing need to reduce medical waste in healthcare settings
    • 3.2.1.2. Rising awareness about the advantages of reprocessed devices
    • 3.2.1.3. Increasing level of supply chain cost savings in healthcare facilities
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Possibility of material change and cross-contamination with reprocessed equipment
    • 3.2.2.2. Prejudice regarding the quality of reprocessed medical devices
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis

Chapter 4. Reprocessed Medical Devices Market Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1. Reprocessed Medical Devices Market: Product Movement Analysis and Market Share
• 4.2. Reprocessed Medical Devices Market: Segment Dashboard
• 4.3. Cardiovascular Devices
  • 4.3.1. Cardiovascular devices market, 2018 - 2030 (USD Million)
  • 4.3.2. Blood Pressure Cuffs
    • 4.3.2.1. Blood Pressure Cuffs market, 2018 - 2030 (USD Million)
  • 4.3.3. Positioning Devices
• 4.3. Positioning Devices market, 2018 - 2030 (USD Million)
  • 4.3.4. Cardiac Stabilization Devices
    • 4.3.4.1. Cardiac Stabilization Devices market, 2018 - 2030 (USD Million)
  • 4.3.5. Diagnostic Electrophysiology Catheters
    • 4.3.5.1. Diagnostic Electrophysiology Catheters market, 2018 - 2030 (USD Million)
  • 4.3.6. Deep Vein Thrombosis Compression Sleeves
    • 4.3.6.1. Deep Vein Thrombosis Compression Sleeves market, 2018 - 2030 (USD Million)
  • 4.3.7. Electrophysiology Cables
    • 4.3.7.1. Electrophysiology Cables market, 2018 - 2030 (USD Million)
• 4.4. Laparoscopic Devices
  • 4.4.1. Laparoscopic devices market, 2018 - 2030 (USD Million)
  • 4.4.2. Harmonic Scalpels
    • 4.4.2.1. Harmonic Scalpels market, 2018 - 2030 (USD Million)
  • 4.4.3. Endoscopic Trocars
    • 4.4.3.1. Endoscopic Trocars market, 2018 - 2030 (USD Million)
• 4.5. Gastroenterology Devices
  • 4.5.1. Gastroenterology devices market, 2018 - 2030 (USD Million)
  • 4.5.2. Biopsy Forceps
    • 4.5.2.1. Biopsy Forceps market, 2018 - 2030 (USD Million)
  • 4.5.3. Others
    • 4.5.3.1. Others market, 2018 - 2030 (USD Million)
• 4.6. General Surgery Devices
  • 4.6.1. General surgery devices, market, 2018 - 2030 (USD Million)
  • 4.6.2. Pressure Bags
    • 4.6.2.1. Pressure Bags market, 2018 - 2030 (USD Million)
  • 4.6.3. Balloon Inflation Devices
    • 4.6.3.1. Balloon Inflation Devices market, 2018 - 2030 (USD Million)
• 4.7. Orthopedic Devices
  • 4.7.1. Orthopedic devices market, 2018 - 2030 (USD Million)

Chapter 5. Reprocessed Medical Devices Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 5.1. Reprocessed Medical Devices Market: Type Movement Analysis and Market Share
• 5.2. Reprocessed Medical Devices Market: Type Segment Dashboard
• 5.3. Third-Party Reprocessing
  • 5.3.1. Third-party reprocessing market, 2018 - 2030 (USD Million)
• 5.4. In-House Reprocessing
  • 5.4.1. In-house reprocessing market, 2018 - 2030 (USD Million)

Chapter 6. Reprocessed Medical Devices Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 6.1. Reprocessed Medical Devices Market: End-Use Movement Analysis and Market Share
• 6.2. Reprocessed Medical Devices Market: End-Use Segment Dashboard
• 6.3. Hospitals
  • 6.3.1. Hospitals market, 2018 - 2030 (USD Million)
• 6.4. Home Healthcare
  • 6.4.1. Home healthcare market, 2018 - 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 7. Region, By Product, By End Use, 2018- 2030 (USD Million)

• 7.1. Regional Market Dashboard
• 7.2. Regional marketplace: Key takeaways
• 7.3. North America
  • 7.3.1. North America reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework and reimbursement scenario
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework and reimbursement scenario
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework and reimbursement scenario
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico reprocessed medical devices market, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework and reimbursement scenario
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework and reimbursement scenario
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework and reimbursement scenario
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework and reimbursement scenario
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework and reimbursement scenario
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.7. Norway
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework and reimbursement scenario
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Norway reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework and reimbursement scenario
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Sweden reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.4.9. Denmark
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework and reimbursement scenario
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Denmark reprocessed medical devices market, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework and reimbursement scenario
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework and reimbursement scenario
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework and reimbursement scenario
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework and reimbursement scenario
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework and reimbursement scenario
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework and reimbursement scenario
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand reprocessed medical devices market, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework and reimbursement scenario
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework and reimbursement scenario
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina reprocessed medical devices market, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework and reimbursement scenario
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework and reimbursement scenario
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework and reimbursement scenario
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE reprocessed medical devices market, 2018 - 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework and reimbursement scenario
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait reprocessed medical devices market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Stryker
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Innovative Health
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. NEScientific, Inc.
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Medline Industries, LP.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Arjo
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Cardinal Health
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. SureTek Medical
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Soma Tech Intl
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Johnson & Johnson MedTech
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. GE Healthcare
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives

관련자료